Advertisement
Advertisement
PAHC
Phibro Animal Health Corporation Class A
53.10
USDSponsored
+3.10
+6.20%
Feb 06, 15:59 UTC -5
Closed
After-Market
53.39
+0.29
+0.55%
PAHC Earnings Reports
Positive Surprise Ratio
PAHC beat 25 of 40 last estimates.
63%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$371.23M
/$0.69
Implied change from Q2 26 (Revenue/ EPS)
-0.72%
/-20.69%
Implied change from Q3 25 (Revenue/ EPS)
+6.74%
/+9.52%
Phibro Animal Health Corporation Class A earnings per share and revenue
On Feb 04, 2026, PAHC reported earnings of 0.87 USD per share (EPS) for Q2 26, beating the estimate of 0.68 USD, resulting in a 27.30% surprise. Revenue reached 373.90 million, compared to an expected 362.75 million, with a 3.07% difference. The market reacted with a +21.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.69 USD, with revenue projected to reach 371.23 million USD, implying an decrease of -20.69% EPS, and decrease of -0.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Canopy Growth Corporation Common Shares
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.13
Surprise
-198.00%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
FAQ
What were Phibro Animal Health Corporation Class A's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Phibro Animal Health Corporation Class A reported EPS of $0.87, beating estimates by 27.3%, and revenue of $373.90M, 3.07% above expectations.
How did the market react to Phibro Animal Health Corporation Class A's Q2 2026 earnings?
The stock price moved up 21.95%, changed from $41.00 before the earnings release to $50.00 the day after.
When is Phibro Animal Health Corporation Class A expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Phibro Animal Health Corporation Class A's next earnings report?
Based on 6
analysts, Phibro Animal Health Corporation Class A is expected to report EPS of $0.69 and revenue of $371.23M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement